SCHEMBL21029776

SCHEMBL21029776

CSN[C@H](CCC(=O)C(C)C)C(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18513359 0.91 NOD1 (0.34) —
SCHEMBL21029641 0.89 — —
SCHEMBL24468878 0.79 — —
SCHEMBL22844805 0.77 — —
SCHEMBL278867 0.77 — —
SCHEMBL21216105 0.76 ACE (0.38) —
SCHEMBL21029881 0.76 — —
SCHEMBL23685458 0.76 ALDH1A1 (0.41) —
SCHEMBL10308346 0.76 ALDH1A1 (0.41) —
SCHEMBL25773839 0.76 MMP3 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190160176-A1 TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS ARBUTUS BIOPHARMA CORPORATION (CA) 2019-05-30 — — US disclosed
Send feedback